Abstract:Background and Purpose: Atherosclerosis is vascular disease of chronic inflammation and lipid disorder, which is a major cause of coronary heart disease. Foam cell formation is key progress during the atherosclerosis development. Insulin-like growth factor (IGF)-1 is a growth hormone that plays a crucial role in growth, metabolism, and homeostasis. Previous studies have demonstrated that increase in circulating IGF-1 can reduce atherosclerotic burden. However, active IGF-1 is characterized with poor tissue retention and is at a very low level in circulation system. Therefore, supplementation of exogenous IGF-1 to restore the physiological level is a promising approach to inhibit atherosclerosis. In this study, we develop a self-assembling, anti-inflammatory drug-modified peptide derived from IGF-1 to mimic IGF-1 bioactivity and simultaneously with an anti-inflammatory property for the treatment of atherosclerosis. Methods: ApoE(-/-) mice were subcutaneously (s.c.) injected with the different hydrogels or natural IGF-1 protein solution per week and simultaneously fed a high-fat diet for 16 weeks. Atherosclerotic lesion formation and stability were assessed after treatment. Moreover, peritoneal macrophage and serum samples were collected to determine lipid profile and inflammatory cytokines. Concurrently, we determined the effect of bifunctional supramolecular nanofibers/hydrogel on cholesterol efflux, foam cell formation, phenotypic transformation of VSMC to macrophage-like cells, and macrophage polarization in vitro or in vivo. Results: Bifunctional supramolecular nanofibers/hydrogel for the treatment of atherosclerosis was formed by a short peptide consisting of a tetrapeptide SSSR from C-region of growth factor IGF-1, an anti-inflammatory drug naproxen (Npx), and a powerful self-assembling D-peptide (FF)-F-D-F-D. The resulting hydrogel of Npx-(D)F(D)FGSSSR (Hydrogel 1, H1) possessed both the anti-inflammatory and IGF-1 mimicking properties, and it efficiently promoted the expression of ABCA1 and ABCG1, thereby significantly reducing cholesterol accumulation in macrophages and preventing foam cell formation. Moreover, H1 markedly inhibited the transformation of vascular smooth muscle cells (VSMCs) into macrophage-like cells which also contributed to foam cell formation. In addition, H1 significantly reduced the inflammatory response in vitro and in vivo. Most importantly, the IGF-1 mimetic peptide showed comparable performance to IGF-1 in vivo and inhibited atherosclerosis by markedly reducing lesion area and enhancing plaque stability. Conclusions: Our study provides a novel supramolecular nanomaterial to inhibit pathological progress of atherosclerosis through regulating cholesterol efflux and inflammation, which may contribute to the development of a promising nanomedicine for the treatment of atherosclerosis in the clinic.

Front Cover: A Collagen‐Derived Oligopeptide from <i>Salmo salar</i> Collagen Hydrolysates Restrains Atherogenesis in ApoE <sup>–/–</sup> Mice via Targeting P <sub>2</sub> Y <sub>12</sub> Receptor

A Collagen-Derived Oligopeptide from Salmo salar Collagen Hydrolysates Restrains Atherogenesis in ApoE-/- Mice via Targeting P2 Y12 Receptor

Purification and Characterization of Novel Collagen Peptides against Platelet Aggregation and Thrombosis from Salmo salar

Purification and Characterization of Novel Collagen Peptides against Platelet Aggregation and Thrombosis from <i>Salmo salar</i>

Effect of Oral Administration of Collagen Peptide OG-5 on Advanced Atherosclerosis Development in ApoE−/− Mice

Various Bioactive Peptides in Collagen Hydrolysate from Salmo Salar Skin and the Combined Inhibitory Effects on Atherosclerosis in Vitro and in Vivo

Yak Bone Collagen-Derived Anti-Inflammatory Bioactive Peptides Alleviate Lipopolysaccharide-Induced Inflammatory by Inhibiting the Nf-Kb Signaling Pathway and Nitric Oxide Production

A Novel Atlantic Salmon (salmo Salar) Bone Collagen Peptide Delays Osteoarthritis Development by Inhibiting Cartilage Matrix Degradation and Anti-Inflammatory

The Hydrogen Sulfide Donor, Gyy4137, Exhibits Anti-Atherosclerotic Activity in High Fat Fed Apolipoprotein E-/- Mice

The Pro-Gly or Hyp-Gly Containing Peptides from Absorbates of Fish Skin Collagen Hydrolysates Inhibit Platelet Aggregation and Target P2Y12 Receptor by Molecular Docking.

Separation and identification of collagen peptides derived from enzymatic hydrolysate of Salmo salar skin and their anti-inflammatory activity in lipopolysaccharide (LPS)-induced RAW264.7 inflammatory model

A novel di-peptide Met-Glu from collagen hydrolysates inhibits platelet aggregation and thrombus formation via regulation of Gq-mediated signaling

Osteogenic Peptides in Collagen Hydrolysates: Stimulate Differentiation of MC3T3-E1 Cells Via Β1 Integrin-Fak-erk1/2 Signaling Pathway and Smad1 Protein

A Novel Sialoglycopeptide from Gadus Morhua Eggs Prevents Liver Fibrosis Induced by CCl4 Via Downregulating FXR/FGF15 and TLR4/TGF-β/Smad Pathways.

Structural Insights on Hyp-Gly-Containing Peptides as Antiplatelet Compounds through Topomer CoMFA and CoMSIA Analysis

Anti-Obesity Effects of Collagen Peptide Derived from Skate (Raja kenojei) Skin Through Regulation of Lipid Metabolism

Tripeptide Hyp-Asp-Gly from Collagen Peptides Inhibited Platelet Activation Via Regulation of PI3K/Akt-MAPK/ERK1/2 Signaling Pathway.

Structural Characterization, Erythrocyte Protection, and Antifatigue Effect of Antioxidant Collagen Peptides from Tilapia (oreochromis Nilotica L.) Skin.

Marine Phospholipids from Fishery By‐Products Attenuate Atherosclerosis

[The Lipid-Lowering and Antioxidative Effects of Marine Collagen Peptides].

Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE -/- mice.